BAXTER INTERNATIONAL INC (BAX) Stock News
NYSE:BAX - New York Stock Exchange, Inc. - US0718131099 - Common Stock - Currency: USD
BAX Latest News, Press Relases and Analysis
These S&P500 stocks are moving in today's session
Let's delve into the developments on the US markets one hour before the close of the markets on Monday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
UBS Upgrades Gerdau S.A. (GGB), Lifts Price Target Amid US Steel Tariffs
Gerdau S.A. (NYSE:GGB) is among the 10 Most Undervalued Stocks to Buy for Under $5. Earlier this week, UBS upgraded the stock’s rating from Neutral to Buy and also increased its share price target to $ 3.80 from $ 2.90 previously. The new price target represents a 26% upside potential from its current trading levels. […]
Kombucha firm Rowdy Mermaid bought by investors led by Next in Natural
New York-based Next in Natural was joined by “strategic investors” KarpReilly and Sapient Stews founder Luke Comer.
Mentions: RCL
7 key quotes from investor Bill Ackman that could make you wealthier
Here are seven key lessons from Bill Ackman about how to succeed at investing.
BAXTER TO Present at Goldman Sachs 46th Annual Global Healthcare Conference 2025
BAX Stock May Rise Following the Launch of FDA-Approved Hemopatch Pad
Baxter launches Hemopatch Sealing Hemostat, an FDA-approved collagen pad designed for effective hemostasis and sealing in both open and minimally invasive surgeries.
Baxter Declares Quarterly Dividend
BAX Stock Gains Following Q1 Earnings Beat Estimates, Revenues Up Y/Y
Baxter reports better-than-expected first-quarter results. However, the company's gross margin contracts. Shares rise in pre-market.
Baxter (BAX) Reports Q1 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Baxter (BAX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Baxter Reports First-Quarter 2025 Results
Conagra to sell Chef Boyardee to private equity firm for $600M
The sale comes as the CPG giant focuses on its core snacks and frozen meals offerings, including Slim Jim and Healthy Choice.
MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK
The medical device industry is growing fast in 2025, but faces supply and trade issues. Major companies to report earnings on May 1, stay tuned!
Baxter to Present at Bank of America Securities 2025 Health Care Conference
Will BAX's Q1 Earnings Improve Following Transformation Completion?
Baxter's first-quarter results are likely to reflect the favorable impact of kidney care sales. Growth in infusion therapies, pharmaceuticals and patient support systems to continue.
Baxter to Host First-Quarter 2025 Financial Results Conference Call for Investors
BAX Stock Declines Despite Latest Product Launch Boosting Patient Care
Baxter aims to promote enhanced patient care through the evolution of its latest product, which enables direct accessibility in the operating room.